Literature DB >> 15826503

The association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans.

Jin-Ho Choi1, Shu-Ying Zhang, Kyung-Woo Park, Young-Seok Cho, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, Hyo-Soo Kim.   

Abstract

5-HT2A is one of major serotonin receptor that is involved in the action of serotonin-targeting drugs. Previous clinical studies have shown an unexpected association between lower cholesterol level and psychiatric diseases, in which T102C polymorphism of HTR2A, gene of 5-HT2A serotonin receptor, might be involved. Therefore, we hypothesized a potential association between lower cholesterol level and T102C polymorphism. The effect of the T102C polymorphism on the serum lipid profiles of 646 subjects without specific psychiatric disease was investigated. Genotype was determined by polymerase chain reaction and restriction fragment length polymorphism analysis. There were significantly lower levels of total cholesterol (193.6 +/- 35.0 versus 202.1 +/- 45.5 mg/dl, p = 0.016) and HDL-cholesterol (42.7 +/- 11.6 versus 46.3 +/- 12.7 mg/dl, p = 0.004) in CC genotype than non-CC genotypes. Moreover, multivariate analysis showed that the CC genotype is a strong predictor of a lower HDL-cholesterol level (p < 0.001). In conclusion, this study shows that the CC genotype of the HTR2A gene is related to lower HDL-cholesterol level in Koreans. This is the first demonstration showing the potential genetic relationship between the serotonin receptor gene polymorphism and the HDL-cholesterol level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826503     DOI: 10.5483/bmbrep.2005.38.2.238

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  2 in total

1.  Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Authors:  Charles D Nichols
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-13

2.  Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.

Authors:  Dora Koller; Susana Almenara; Gina Mejía; Miriam Saiz-Rodríguez; Pablo Zubiaur; Manuel Román; Dolores Ochoa; Marcos Navares-Gómez; Elena Santos-Molina; Elena Pintos-Sánchez; Francisco Abad-Santos
Journal:  Adv Ther       Date:  2020-12-05       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.